Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.36 USD | +4.49% | -3.15% | 0.00% |
04-30 | Morgan Stanley Starts Contineum Therapeutics With Overweight Rating | MT |
04-30 | Stifel Starts Contineum Therapeutics With Buy Rating, $29 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 395M | |
+48.67% | 56.69B | |
-2.76% | 41B | |
+38.11% | 38.11B | |
-11.22% | 26.89B | |
+9.25% | 25.59B | |
-23.10% | 18.59B | |
+1.88% | 12.39B | |
+26.43% | 11.99B | |
+21.74% | 11.88B |
- Stock Market
- Equities
- CTNM Stock
- News Contineum Therapeutics, Inc.
- RBC Initiates Contineum Therapeutics at Outperform, Speculative Risk With $30 Price Target